The Proof

→ WHAT IT COVERS Dr. Nicola Guess analyzes a Washington University study comparing ketogenic, Mediterranean, and plant-forward diets in prediabetic adults, arguing the 67% liver fat reduction attributed to keto was driven primarily by high protein intake rather than carbohydrate restriction or ketone production. → KEY INSIGHTS - **Protein, not ketones, drives liver fat reduction:** The study's "ketogenic" diet produced ketone levels of only 0.5 mmol/L, far below the 1.

→ WHAT IT COVERS Stanford nutrition professor Dr. Christopher Gardner reflects on 30 years of clinical diet trials, covering what the evidence does and does not prove about dietary patterns, fermented foods, protein sources, ketogenic versus Mediterranean diets, and why the gap between rigorous science and real-world generalizability remains the central unsolved challenge in nutrition research. → KEY INSIGHTS - **Null findings matter:** Gardner's $1.

→ WHAT IT COVERS Simon Hill, MSc, details the 16.5-month lifestyle protocol behind his coronary plaque scan results, explains why three different AI and human-reviewed analysis platforms produced wildly divergent readings of the same scans, and reveals his decision to start Repatha (evolocumab), a PCSK9 inhibitor, targeting an ApoB of 40 mg/dL. → KEY INSIGHTS - **Cumulative LDL exposure:** Atherosclerosis risk is determined by lifetime ApoB exposure, not current levels.

→ WHAT IT COVERS Orthopedic surgeon Dr. Howard Luks explains why MRI findings like rotator cuff tears, labral tears, and meniscus tears are frequently age-appropriate changes rather than surgical emergencies. He outlines how metabolic health, financial incentives, and language choices shape treatment decisions, and when surgery genuinely produces better outcomes than physical therapy.

→ WHAT IT COVERS Dr. Federica Amati covers the second half of the first thousand days framework, examining how birth mode, breastfeeding, and early feeding shape long-term health. Topics include key pregnancy nutrients (choline, iodine, DHA), vaginal microbiome preparation, infant gut microbiome development, formula versus breast milk outcomes, weaning with whole foods, and microplastic exposure reduction strategies.

→ WHAT IT COVERS Prof Aleksander Krag, hepatologist and European Liver Society former president, explains that roughly 30% of the global population has steatotic liver disease — most undetected until advanced stages. He covers how fat accumulates in the liver, the role of alcohol and metabolic dysfunction, fibrosis progression timelines, screening methods, and two newly FDA-approved treatments.

→ WHAT IT COVERS Lipidologists Thomas Dayspring and Dan Soffer examine primary prevention of atherosclerosis, covering how ApoB-containing lipoproteins drive plaque formation, when to initiate lipid-lowering therapy before a cardiovascular event occurs, how the 2026 dyslipidemia guidelines expand risk assessment to age 30, and which pharmacologic options—statins, ezetimibe, and PCSK9 inhibitors—best reduce long-term cardiovascular risk.

→ WHAT IT COVERS Geriatrician and gerontologist Deborah Kado discusses bone health, fall prevention, osteoporosis medications, and what actually predicts functional independence in older adults. Drawing on 30+ years of clinical experience, she covers the four M's framework used in geriatric care, bisphosphonate risks and benefits, deprescribing, the microbiome-vitamin D connection, and why healthy longevity is a more useful concept than health span.

→ WHAT IT COVERS Prof. Roy Taylor returns to The Proof to update his twin cycle hypothesis of type 2 diabetes, presenting five-year DIRECT trial data showing sustained weight loss and remission, comparing dietary intervention against GLP-1 medications, and exploring gestational diabetes prevention through the same fat-threshold framework that underpins his original 2011 research.

→ WHAT IT COVERS Dr. Nicola Guess, Oxford dietitian and researcher, presents evidence that high-protein, low-carbohydrate diets can lower blood glucose in type 2 diabetes by more than medications — approximately 4 mmol/L postprandially — without any weight loss, offering an alternative pathway for the 60-65 age group who cannot or will not lose 10 kilograms.

→ WHAT IT COVERS Dr Michael Eisenberg, Stanford urologist and male fertility specialist, joins reproductive endocrinologist Dr Natalie Crawford to examine why male fertility testing is systematically neglected. They cover semen analysis parameters, how sperm health predicts long-term disease risk, the damage caused by unsupervised testosterone use, declining global sperm counts, paternal age effects, and concrete steps men can take to optimize reproductive and overall health.

→ WHAT IT COVERS Simon Hill and surgeon Terry Simpson examine cardiovascular disease risk, cholesterol management, and emerging therapies including oral PCSK9 inhibitors and gene-editing treatments. They analyze a contested ketogenic diet plaque study, address misinformation from health influencers, and cover superager brain health research, colorectal cancer screening, and new 2026 dyslipidemia guidelines across 113 minutes.

→ WHAT IT COVERS Exercise physiologist Inigo San Millán and researchers Roy Taylor and Kevin Hall join host Simon Hill to examine how mitochondrial function drives metabolic health, why lactate is a biomarker of cellular fitness rather than a waste product, how Zone 2 training reverses metabolic dysfunction, and what Roy Taylor's twin cycle hypothesis reveals about the reversibility of type 2 diabetes through targeted fat loss.

→ WHAT IT COVERS Three physicians and a nutrition researcher examine the science behind GLP-1 receptor agonists — semaglutide and tirzepatide — covering how food noise, leptin resistance, and gut peptide signaling drive obesity, why willpower-based approaches fail for many people, and how diet quality, resistance training, and protein intake determine long-term outcomes when using these medications. → KEY INSIGHTS - **Food Noise vs.

→ WHAT IT COVERS Nutritionist Federica Amati outlines the science behind the "first 1,000 days" — from 90 days preconception through a child's second birthday — explaining how parental nutrition, sperm and egg quality, and the in-utero environment set the biological foundation for a child's lifelong metabolic, cognitive, and cardiovascular health outcomes. → KEY INSIGHTS - **The 90-Day Preconception Window:** Both sperm and egg quality respond to lifestyle changes within roughly 90 days.

→ WHAT IT COVERS Interventional cardiologist Campbell Rogers explains how HeartFlow's AI analysis of coronary CT angiograms can quantify plaque volume and composition with far greater precision than standard calcium scoring or traditional CT reads. The episode uses host Simon Hill's two personal scans, taken 16 months apart, to demonstrate how this technology can detect early disease and track treatment response.

→ WHAT IT COVERS Simon Hill reviews eight supplements ranked by human trial evidence for reversing arterial plaque, covering EPA, aged garlic extract, vitamin K2, niacin, CoQ10, berberine, nattokinase, and pomegranate extract. He evaluates imaging studies and cardiovascular outcome trials to determine which supplements genuinely regress atherosclerosis versus which improve biomarkers without delivering measurable arterial benefit.

→ WHAT IT COVERS Internal medicine physician and endocrinology fellow Mauricio Gonzalez covers metabolic organ health as the new standard for measuring wellness, explaining why liver fat matters more than body weight, how GLP-1 medications work in clinical practice, optimal nutrition strategies for patients on these drugs, and minimum effective doses for resistance training and cardiovascular exercise.

→ WHAT IT COVERS Exercise physiologist Margie Davenport, who chaired the 2019 Canadian pregnancy exercise guidelines and the 2025 International Olympic Committee consensus statement, presents randomized controlled trial evidence showing that exercise during pregnancy reduces gestational diabetes, preeclampsia, and prenatal depression by 40–67%, while dismantling decades of myths around heart rate limits, heavy lifting, and fetal safety.

→ WHAT IT COVERS Dr Federica Amati, head of nutrition science at ZOE and author of The Appetite Reset, explains the biology of appetite regulation across three distinct hunger types, how GLP-1 medications interact with the gut-brain satiety system, and what nutritional strategies — covering fiber, protein, and micronutrients — are required before, during, and after GLP-1 treatment to preserve muscle mass and metabolic health.